- view as grid
- view as list
This brief discusses how drugs provided in inpatient hospital settings are covered and reimbursed for beneficiaries in traditional Medicare under current law. This is relevant for Medicare spending on COVID-19 patients who receive Gilead’s new antiviral drug remdesivir. We discuss the possible scenarios for hospitals and the Medicare program depending on different pricing levels for the drug.
In light of heightened attention to insulin and the Trump Administration’s new Part D model to address out-of-pocket costs for insulin for Medicare beneficiaries, we analyzed out-of-pocket spending on insulin by beneficiaries enrolled in Part D drug plans, variation in Part D plan formulary coverage and tier placement of insulin products, and trends in prices for insulin.
In this Axios column, Drew Altman analyzes recent unemployment numbers for older workers and discusses how millions of uninsured older workers could lead to a greater push for incremental Medicare expansion proposals.
This brief analyzes the changes to telehealth regulation and implementation made by the federal government, state governments and health systems in response to the COVID-19 emergency. We outline key changes to telemedicine coverage, for Medicare, Medicaid and private insurers.
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries.
This analysis examines the income, savings, and home equity of Medicare beneficiaries in 2019, before the coronavirus pandemic. We look at the overall population, and variations by age, gender and race/ethnicity.
The highly transmissible nature of the coronavirus combined with the congregate nature of long-term care facility settings and the close and personal contact that many long-term care workers have with patients puts them at elevated risk of infection. This analysis focuses on the characteristics of the 4.5 million people who work in long-term care settings, based on the 2018 American Community Survey.
KFF Analysis: Number of Coronavirus Cases, Distribution of $30B in CARES Act funding and Medicare Advantage Penetration by State
Number of Coronavirus Cases, Distribution of $30B in CARES Act funding and Medicare Advantage Penetration by State State Number of COVID-19 Cases on April 21, 2020 Percent of Total COVID-19 Cases First Distribution of CARES Act Payments Percent of Total Money Distributed Percent of Medicare Beneficiaries in Medicare Advantage, 2020…
Medicare Advantage enrollment has grown rapidly over the past decade, and Medicare Advantage plans have taken on a larger role in the Medicare program. More than 24 million Medicare beneficiaries (36%) are enrolled in Medicare Advantage plans in 2020. This data analysis provides updated information about Medicare Advantage enrollment trends, premiums, and out-of-pocket limits. It also includes analyses of Medicare Advantage plans’ extra benefits and prior authorization requirements. The analysis also highlights changes pertaining to Medicare Advantage coverage that have occurred in 2020 in response to the COVID-19 crisis.